Quoin Pharmaceuticals Statistics
Share Statistics
Quoin Pharmaceuticals has 588.17K
shares outstanding. The number of shares has increased by 135.73%
in one year.
| Shares Outstanding | 588.17K |
| Shares Change (YoY) | 135.73% |
| Shares Change (QoQ) | 77.2% |
| Owned by Institutions (%) | 0.03% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 3 |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 19.18K, so 0.09% of the outstanding
shares have been sold short.
| Short Interest | 19.18K |
| Short % of Shares Out | 0.09% |
| Short % of Float | 0.1% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
| PE Ratio | 0 |
| Forward PE | -15.6 |
| PS Ratio | 0 |
| Forward PS | 0.1 |
| PB Ratio | 0 |
| P/FCF Ratio | -0.39 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Quoin Pharmaceuticals.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.57,
with a Debt / Equity ratio of 0.
| Current Ratio | 3.57 |
| Quick Ratio | 3.57 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-2,987,490,666.67 |
| Employee Count | 3 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -8.95B |
| Effective Tax Rate | 99.9% |
Stock Price Statistics
The stock price has increased by 869.07% in the
last 52 weeks. The beta is 1.6, so Quoin Pharmaceuticals's
price volatility has been higher than the market average.
| Beta | 1.6 |
| 52-Week Price Change | 869.07% |
| 50-Day Moving Average | 7.34 |
| 200-Day Moving Average | 2.26 |
| Relative Strength Index (RSI) | 61.21 |
| Average Volume (20 Days) | 211,609 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | n/a |
| Net Income | -8.96B |
| EBITDA | -8.9M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1911.5 |
Full Income StatementBalance Sheet
The company has 3.62M in cash and 0 in
debt, giving a net cash position of 3.62M.
| Cash & Cash Equivalents | 3.62M |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -55.17B |
| Total Assets | 15.71M |
| Working Capital | 10.75M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -7.89M
and capital expenditures 0, giving a free cash flow of -7.86M.
| Operating Cash Flow | -7.89M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.86M |
| FCF Per Share | -1.68 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
